|
UCSF Chimera?A visualization system for exploratory research and analysis
|
journal
|
January 2004 |
|
Ornithine aminotransferase promoted the proliferation and metastasis of non‐small cell lung cancer via upregulation of miR‐21
|
journal
|
December 2018 |
|
Ornithine Aminotransferase versus GABA Aminotransferase: Implications for the Design of New Anticancer Drugs: ORNITHINE AMINOTRANSFERASE VS. GABA AMINOTRANSFERASE
|
journal
|
August 2014 |
|
Theoretical calculation of the pKa values of some drugs in aqueous solution
|
journal
|
August 2011 |
|
The Multiple Active Enzyme Species of γ-Aminobutyric Acid Aminotransferase Are Not Isozymes
|
journal
|
February 2000 |
|
Crystal structure of human recombinant ornithine aminotransferase
|
journal
|
March 1998 |
|
Crystal structure of human ornithine aminotransferase complexed with the highly specific and potent inhibitor 5-fluoromethylornithine 1 1 1Edited by R. Huber
|
journal
|
January 1999 |
|
Optimization of parameters for semiempirical methods VI: more modifications to the NDDO approximations and re-optimization of parameters
|
journal
|
November 2012 |
|
Mechanism of inactivation of γ-aminobutyric acid aminotransferase by ( S,E )-4-amino-5-fluoropent-2-enoic acid
|
journal
|
February 1988 |
|
[10] Mechanism-based enzyme inactivators
|
book
|
January 1995 |
|
Highly selective directed hydrogenation of enantiopure 4-( tert -butoxycarbonylamino)cyclopent-1-enecarboxylic acid methyl esters
|
journal
|
February 2001 |
|
Structure, evolution and action of vitamin B6-dependent enzymes
|
journal
|
December 1998 |
|
Two continuous coupled assays for ornithine-δ-aminotransferase
|
journal
|
September 2013 |
|
Syntheses and evaluation of fluorinated conformationally restricted analogues of GABA as potential inhibitors of GABA aminotransferase
|
journal
|
April 2006 |
|
Synthesis of neplanocin F analogues as potential antiviral agents
|
journal
|
December 2006 |
|
Revisit of aminotransferase in the genomic era and its application to biocatalysis
|
journal
|
December 2005 |
|
Selective Targeting by a Mechanism-Based Inactivator against Pyridoxal 5′-Phosphate-Dependent Enzymes: Mechanisms of Inactivation and Alternative Turnover
|
journal
|
September 2017 |
|
Design and Mechanism of GABA Aminotransferase Inactivators. Treatments for Epilepsies and Addictions
|
journal
|
February 2018 |
|
Synthesis of ( S )-3-Amino-4-(difluoromethylenyl)-cyclopent-1-ene-1-carboxylic Acid (OV329), a Potent Inactivator of γ-Aminobutyric Acid Aminotransferase
|
journal
|
July 2018 |
|
Theoretical and Mechanistic Validation of Global Kinetic Parameters of the Inactivation of GABA Aminotransferase by OV329 and CPP-115
|
journal
|
March 2021 |
|
Suppression of Hepatocellular Carcinoma by Inhibition of Overexpressed Ornithine Aminotransferase
|
journal
|
June 2015 |
|
Mechanism-Based Design of 3-Amino-4-Halocyclopentenecarboxylic Acids as Inactivators of GABA Aminotransferase
|
journal
|
February 2020 |
|
Mechanism of inactivation of .gamma.-aminobutyrate aminotransferase by 4-amino-5-fluoropentanoic acid. First example of an enamine mechanism for a .gamma.-amino acid with a partition ratio of 0
|
journal
|
November 1986 |
|
Mechanism of inactivation of .gamma.-aminobutyric acid-.alpha.-ketoglutaric acid aminotransferase by 4-amino-5-halopentanoic acids
|
journal
|
March 1981 |
|
Mechanistic Crystallography. Mechanism of Inactivation of γ-Aminobutyric Acid Aminotransferase by (1 R ,3 S ,4 S )-3-Amino-4-fluorocyclopentane-1-carboxylic Acid As Elucidated by Crystallography †
|
journal
|
November 2004 |
|
Mechanisms of inactivation of .gamma.-aminobutyric acid aminotransferase by the antiepilepsy drug .gamma.-vinyl GABA (vigabatrin)
|
journal
|
November 1991 |
|
Mechanism of Inactivation of γ-Aminobutyric Acid Aminotransferase by (1 S ,3 S )-3-Amino-4-difluoromethylene-1-cyclopentanoic Acid (CPP-115)
|
journal
|
February 2015 |
|
Mechanisms of Inactivation of γ-Aminobutyric Acid Aminotransferase by 4-Amino-5-fluoro-5-hexenoic Acid
|
journal
|
January 1996 |
|
A Remarkable Difference That One Fluorine Atom Confers on the Mechanisms of Inactivation of Human Ornithine Aminotransferase by Two Cyclohexene Analogues of γ-Aminobutyric Acid
|
journal
|
March 2020 |
|
Turnover and Inactivation Mechanisms for ( S )-3-Amino-4,4-difluorocyclopent-1-enecarboxylic Acid, a Selective Mechanism-Based Inactivator of Human Ornithine Aminotransferase
|
journal
|
June 2021 |
|
Rational Design, Synthesis, and Mechanism of (3S,4R)-3-Amino-4-(difluoromethyl)cyclopent-1-ene-1-carboxylic Acid: Employing a Second-Deprotonation Strategy for Selectivity of Human Ornithine Aminotransferase over GABA Aminotransferase
|
journal
|
March 2022 |
|
Design and Mechanism of ( S )-3-Amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic Acid, a Highly Potent γ-Aminobutyric Acid Aminotransferase Inactivator for the Treatment of Addiction
|
journal
|
January 2018 |
|
Mechanism of Inactivation of Ornithine Aminotransferase by (1 S ,3 S )-3-Amino-4-(hexafluoropropan-2-ylidenyl)cyclopentane-1-carboxylic Acid
|
journal
|
June 2019 |
|
A New Class of Conformationally Rigid Analogues of 4-Amino-5-halopentanoic Acids, Potent Inactivators of γ-Aminobutyric Acid Aminotransferase
|
journal
|
February 2000 |
|
Synthesis of (E)-4-amino-2,5-hexadienoic acid and (E)-4-amino-5-fluoro-2-pentenoic acid. Irreversible inhibitors of 4-aminobutyrate-2-oxoglutarate aminotransferase
|
journal
|
July 1986 |
|
dl-canaline and 5-fluoromethylornithine. Comparison of two inactivators of ornithine aminotransferase
|
journal
|
June 1990 |
|
Resolving the cofactor-binding site in the proline biosynthetic enzyme human pyrroline-5-carboxylate reductase 1
|
journal
|
April 2017 |
|
Vigabatrin: Lessons Learned From the United States Experience
|
journal
|
December 2018 |
|
Phaser crystallographic software
|
journal
|
July 2007 |
|
Features and development of Coot
|
journal
|
March 2010 |
|
Data processing and analysis with the autoPROC toolbox
|
journal
|
March 2011 |
|
Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix
|
journal
|
October 2019 |
|
The GABA Shunt: An Attractive and Potential Therapeutic Target in the Treatment of Epileptic Disorders
|
journal
|
April 2005 |
|
Medicinal Chemistry and the Molecular Operating Environment (MOE): Application of QSAR and Molecular Docking to Drug Discovery
|
journal
|
December 2008 |